One of the principal tools of personalized medicine is the use of companion diagnostics. In this first article in a two-part series on the opportunities and challenges that confront the rise of companion diagnostics, we use case studies to review the different roles that these products and services could play in the continued growth of the pharmaceutical industry. The article can be found here:
Looking under the hood: UK economic outlook and implications
2021 was expected to be a year of recovery and growth – both globally and in the UK. However, as we are now in a race between a more infectious virus strain...